HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome. - Wikidata - awgldk - TriplyDB

HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.

HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.

http://www.wikidata.org/entity/Q35584405

about

A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer Incidence and implications of chemotherapy related hand-foot syndrome.Multikinase Inhibitor-Induced Hand-Foot Skin Reaction: A Review of Clinical Presentation, Pathogenesis, and Management.The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K).Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma.Nasal vestibulitis due to targeted therapies in cancer patients.Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.Dermatologic events from EGFR inhibitors: the issue of the missing patient voice.The risk of hand-foot skin reaction to axitinib, a novel VEGF inhibitor: a systematic review of literature and meta-analysis.Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomised trials.Dermatological toxicity associated with targeted therapies in cancer: optimal management.Capecitabine for the treatment of gastric cancer.Dermatological adverse events with taxane chemotherapy.Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation.A systematic review of measurement properties of patient-reported outcome measures for use in patients with foot or ankle diseases.Hand-foot syndrome following decitabine.Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study.Validation of the Japanese version of HFS-14, a disease-specific quality of life scale for patients suffering from hand-foot syndrome.Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis.A simple home-based self-monitoring tool for early detection of hand-foot syndrome in cancer patients.Falls and Physical Inactivity in Patients with Gastrointestinal Cancer and Hand-Foot Syndrome.

P2860

Q26827266-702516AE-1B77-45B7-A9F0-5E33E563BD40 Q27005701-348D57C5-E30A-4D04-B971-583BD28562E1 Q30244770-2D96FFA1-F15D-4D97-AB09-B39ADCBB93DD Q30250106-B7F0C34B-4B15-4317-AD2C-58B053463753 Q30279166-8C2CFA56-8BA6-4796-B936-2DF7C21CA377 Q30355066-FAC917DB-F663-436A-A6A4-CB1A96877509 Q34207858-B75C416C-DBB2-46D1-B5CD-F8A0455A114E Q35954875-BBAEFC68-2C15-4C87-80A3-DA37C7335EA8 Q36078348-4232FE5D-95F5-432C-9886-F487E5A58DB9 Q37541523-79475D8F-A4B0-4383-ABE7-45D622E4E003 Q38076349-6E1F68FA-5AB9-4BE8-B109-7099B7B3F699 Q38181898-5F149AE3-D35F-4004-B5D3-80D0B895C131 Q38239381-5E073D84-AB48-4EBA-960C-2EB1ECDACD68 Q38608072-807473F8-C976-4789-A97E-A0E8B449E78D Q38934447-B3D8E6F7-4238-4D68-942B-5DA96B418658 Q39048761-B7E196B1-2CDB-40A5-9BF4-9D14B67B4A56 Q39185649-A783EE78-1124-43FC-9F24-4B2D32CA195C Q39615789-924103B3-7A6B-4853-8204-676BC8DE9E3A Q40985350-46EF5715-DAAA-4FFE-B2B0-2BB8EF9FAD1F Q48050225-3AD69BEA-E417-448E-A272-B0900E59929A Q50968798-4DD08C5F-C7FC-4D63-8A94-B01F79A96234 Q54718288-30227AB5-E9FE-4D80-8CFC-D3F16963A343 Q55411619-0255838C-049A-4402-AB17-7DCB810D0B64

P2860

HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.

http://www.wikidata.org/entity/Q35584405

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

HFS-14, a specific quality of ...... ering from hand-foot syndrome.

@ast

HFS-14, a specific quality of ...... ering from hand-foot syndrome.

@en

type

label

HFS-14, a specific quality of ...... ering from hand-foot syndrome.

@ast

HFS-14, a specific quality of ...... ering from hand-foot syndrome.

@en

prefLabel

HFS-14, a specific quality of ...... ering from hand-foot syndrome.

@ast

HFS-14, a specific quality of ...... ering from hand-foot syndrome.

@en

P1433

Q35584405-F6E472F9-E867-4D2B-9E0F-DE42D9E1075F

P1476

Q35584405-1D1F7EB7-DBF0-4504-9A8A-F9A0B3519B53

P2093

Q35584405-09519F29-3B58-4BF3-B002-CFFDD4091973

Q35584405-432657AE-1639-4BAA-AF72-66B9266256EF

Q35584405-696E48E6-167E-422D-A57F-020911CE73BC

Q35584405-C4E0B724-224E-4847-A751-8A6C3811204B

Q35584405-CC3B3F1D-C871-40BD-8A4F-0C399327E0A0

Q35584405-D6D256F2-A175-40D0-90C9-EB45D0975AEE

Q35584405-E6A870CD-2C1B-4D76-A537-8603458F14CE

Q35584405-F7197362-0774-4E6D-AA26-98452FC38184

P2860

Q35584405-044F812F-4A68-44DC-AB21-C7AF2A043106

Q35584405-0E74F3DC-7D64-4056-84AC-3D8148F18AC9

Q35584405-14CD86AE-B7E4-43FC-A458-8A65F5131620

Q35584405-2A33D809-138C-49C5-BDE9-380B12D09460

Q35584405-37D88BA7-1DCF-4D34-91E9-F6351308023F

Q35584405-4797AE8F-50CD-4F10-99F4-CBAE01177AF3

Q35584405-488637CF-5ED3-4B25-8AD6-9FB72724CD90

Q35584405-4B19C27C-98D5-42B1-ABF6-A95989BA630E

Q35584405-4B9E3DD8-0428-4353-A4B2-9C4AAA5AAF07

Q35584405-6585D80B-84DF-46AE-B6AB-BFDFCDD4350A

P304

Q35584405-3527C453-0C47-46DB-B5B8-6BD42017DB08

P31

Q35584405-95CE841D-475A-4A27-8607-CD7C7B336016

P356

Q35584405-EE7AEC73-243A-4661-A931-0A37FAC1ED94

P433

Q35584405-5EDB6C36-BD6D-4208-9E04-6E8AC4095035

P478

Q35584405-95730D02-EB99-4913-BF78-AE01EC8F88CA

P50

Q35584405-5CB9BA04-6C31-4152-8410-5E216605B5B2

P577

Q35584405-5C4AC9BA-D056-454B-8DA8-409C5AAB4CB2

P5875

Q35584405-0525D7BB-909E-45DE-8602-A854A20264D2

P698

Q35584405-6ED139DB-70A9-483A-91E9-42B24CFB0D17

P921

Q35584405-7453BB39-2BC1-48B5-B012-6DA42052DC95

P932

Q35584405-7D80B3E7-A963-4526-9C71-E3EC60318F33

P356

THEONCOLOGIST.2011-0033

P1433

P1476

HFS-14, a specific quality of ...... ering from hand-foot syndrome.

@en

P2093

Charles Taïeb

http://www.w3.org/2001/XMLSchema#string

Christine Chevreau

http://www.w3.org/2001/XMLSchema#string

Florence Dalenc

http://www.w3.org/2001/XMLSchema#string

Henri Roché

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Lacaze

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Delord

http://www.w3.org/2001/XMLSchema#string

Loïc Mourey

http://www.w3.org/2001/XMLSchema#string

Nora Rahhali

http://www.w3.org/2001/XMLSchema#string

P2860

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation

Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts

Chemotherapy-induced acral erythema

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy.

Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management.

10 years experience of the Dermatology Life Quality Index (DLQI).

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation.

Cutaneous side-effects of kinase inhibitors and blocking antibodies.

P304

1469-1478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2011-0033

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51686068

http://www.w3.org/2001/XMLSchema#string

P698

21964002

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

3228077

http://www.w3.org/2001/XMLSchema#string